Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease

Radiology

Volumn 215, Issue 3, 2000, Pages 886-890

  Farrell, Michael A ^a   McAdams, H Page ^a   Herndon, James E ^a   Patz Jr , Edward F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fluorine, radioactive; Lung neoplasms; Lung neoplasms, staging; Lung, CT; Lung, PET; Lymphatic system, neoplasms; Lymphatic system, PET

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0034121859     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.215.3.r00jn29886     Document Type: Article

References (36)

1. Graham ANJ, Chan KJM, Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 1999; 117:246-251.
2. Tsang GMK, Watson DCT. The practice of cardiothoracic surgeons in the preoperative staging of non-small cell lung cancer. Thorax 1992; 47:3-5.
3. Goldstraw P, Rocmans P, Bali D, et al. Pretreatment minimal staging for non-small cell lung cancer: an updated consensus. Lung Cancer 1994; 11(suppl 3):S1-S4.
4. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323.
5. Quint LE, Francis IR, Wahl RL, Gross BH, Glazer GM. Preoperative staging of non-small cell carcinoma of the lung: imaging methods. AJR Am J Roentgenol 1995; 164:1349-1359.
6. Cascade PN, Gross BH, Kazerooni EA, et al. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT. AJR Am J Roentgenol 1998; 170:927-931.
7. Heavey LR, Glazer GM, Gross BH, Frances IR, Orringer MB. The role of CT in staging radiographic T1N0M0 lung cancer. AJR Am J Roentgenol 1986; 146:285-290.
8. Black WC, Armstrong P, Daniel TM. Cost effectiveness of chest CT in T1N0M0 lung cancer. Radiology 1988; 167:373-378.
9. Conces DJ Jr, Klink JF, Tarver RD, Moak GD. T1N0M0 Lung cancer: evaluation with CT. Radiology 1989; 170:643-646.
10. Glazer GM, Orringer MB, Gross BH, Quint LE. The mediastinum in non-small cell lung cancer: CT-surgical correlation. AJR Am J Roentgenol 1984; 142:1101-1105.
11. Hoh CK, PET in oncology: will it replace the other modalities? Semin Nucl Med 1997; 27:94-106.
12. 18F]-FDG in oncology: a clinical update. Nucl Med Biol 1996; 23:717-735.
13. Chin R Jr, Ward R, Keyes JW Jr, et al. Mediastinal staging of non-small cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995; 152:2090-2096.
14. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191:371-377.
15. Patz EF Jr, Lowe VJ, Goodman PC, Herndon J. Thoracic nodal staging with positron emission tomography (PET) and 18FDG in patients with bronchogenic carcinoma. Chest 1995; 108:1617-1621.
16. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16:2142-2149.
17. Steinert H, Hauser M, Allenman F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202:441-446.
18. Kutlu CA, Pastorino U, Maisey M, Goldstraw P. Selective use of PET scan in the preoperative staging of NSCLC. Lung Cancer 1998; 21:177-184.
19. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995; 60:1573-1582.
20. Sazon DAD, Santago SM, Hoo GWS, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996; 153:417-421.
21. Schiepers C. Role of positron emission tomography in the staging of lung cancer. Lung Cancer 1997; 17(suppl 1):S29-S35.
22. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). Thorax 1997; 52: 438-441.
23. Valk PE, Pounds TR, Tesa RD, Hopkins DM, Haseman MK. Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 1996; 23:737-743.
24. Scott WJ, Shepherd J, Gambhir SS. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg 1998; 66:1876-1885.
25. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717.
26. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771-1776.
27. Chen MY, Chiles C, Choplin RH, Aquino SL. Bronchogenic carcinoma: a survey of CT protocols for staging disease. Acad Radiol 1997; 4:687-692.
28. Patz EF Jr, Erasmus JJ, McAdams HP, et al. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax. Radiology 1999; 212:56-60.
29. Gdeedo A, Van Schil P, Corthouts B, Van Mieghem F, Van Meerbeeck J, Van Marck E. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg 1997; 12:224-227.
30. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705-713.
31. Nicholson AG, Graham AN, Pezzella F, Agneta G, Goldstraw P, Pastorino U. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinoma? Lung Cancer 1997; 18:231-240.
32. 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994; 344:1265-1266.
33. Takizawa T, Terashima M, Koike T, Akamatsu H, Kurita Y, Yokoyama A. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg 1997; 113:248-252.
34. Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 1996; 61:177-183.
35. Salerno CT, Frizelle S, Niehans GA, et al. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction. Chest 1998; 113:1526-1532.
36. Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K. Micrometastatic P53-positive cells in the lymph nodes of non-small cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg 1997; 114:339-346.